Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.33 |
| ▸ | USP1 | O94782 | 1/20 | 0.32 |
| ▸ | WDR48 | Q8TAF3 | 1/20 | 0.32 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26772405 | 0.90 | MEN1 (0.35) | MAPK1MAPTL3MBTL1ALDH1A1 | |
| SCHEMBL22547545 | 0.87 | MEN1 (0.33) | MAPK1MAPTL3MBTL1ABCG2ALDH1A1 | |
| SCHEMBL19275956 | 0.83 | MEN1 (0.33) | MAPK1TP53MAPTL3MBTL1ABCG2 | |
| SCHEMBL26772407 | 0.83 | MEN1 (0.39) | MAPTSMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL22596735 | 0.83 | MEN1 (0.33) | MAPK1TP53MAPTL3MBTL1ABCG2 | |
| SCHEMBL23938705 | 0.83 | — | — | |
| SCHEMBL22274284 | 0.82 | MAPK1 (0.46) | MAPK1TP53MAPTNFKB1RAB9A | |
| SCHEMBL24686409 | 0.81 | PLA2G2A (0.30) | — | |
| SCHEMBL22547244 | 0.81 | MAPT (0.32) | MAPK1TP53MAPTRAB9ASMN1; SMN2 | |
| SCHEMBL26290143 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | ALDH1A2, OXER1, AOX1 | MAPK1 82/4885TP53 4817/4885MAPT 2645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.